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OBJECTIVE—The objective of this study was to investigate the
association of 4-year changes in alcohol consumption with a
subsequent risk of type 2 diabetes.
RESEARCH DESIGN AND METHODS—We prospectively ex-
amined 38,031 men from the Health Professionals Follow-Up
Study who were free of diagnosed diabetes or cancer in 1990.
Alcohol consumption was reported on food frequency question-
naires and updated every 4 years.
RESULTS—A total of 1,905 cases of type 2 diabetes occurred
during 428,497 person-years of follow-up. A 7.5 g/day (approxi-
mately half a glass) increase in alcohol consumption over 4 years
was associated with lower diabetes risk among initial nondrink-
ers (multivariable hazard ratio [HR] 0.78; 95% CI: 0.60–1.00) and
drinkers initially consuming 15 g/day (HR 0.89; 95% CI: 0.83–
0.96), but not among men initially drinking 15 g/day (HR 0.99;
95% CI: 0.95–1.02; Pinteraction  0.01). A similar pattern was
observed for levels of total adiponectin and hemoglobin A1c, with
a better metabolic proﬁle among abstainers and light drinkers
who modestly increased their alcohol intake, compared with
men who either drank less or among men who were already
moderate drinkers and increased their intake. Likewise, com-
pared with stable light drinkers (0–4.9 g/day), light drinkers who
increased their intake to moderate levels (5.0–29.9 g/day) had a
signiﬁcantly lower risk of type 2 diabetes (HR 0.75; 95% CI:
0.62–0.90).
CONCLUSIONS—Increases in alcohol consumption over time
were associated with lower risk of type 2 diabetes among initially
rare and light drinkers. This lower risk was evident within a
4-year period following increased alcohol intake. Diabetes 60:
74–79, 2011
A
lcohol consumption has been consistently as-
sociated with a reduced risk of type 2 diabetes
compared with abstention or excessive con-
sumption (1,2). Most prospective studies mea-
sure alcohol consumption at only one point in time which
assumes intake is fairly stable over time. However, alcohol
consumption is dynamic, especially over longer periods of
follow-up (3). Importantly, changes in alcohol consump-
tion over time have been associated with subsequent
changes in risk of cardiovascular diseases (4–6) and
mortality (7), although some inconsistency exists (8,9).
Variability in intake over time thus highlights the con-
straints of single measures of alcohol consumption.
To our knowledge, no observational studies have exam-
ined the association between changes in alcohol consump-
tion over time and future risk of type 2 diabetes, despite
the importance of such studies both in assessing the
robustness of the alcohol-diabetes association and in
addressing a topic of direct clinical importance—what
happens when individuals adopt or cease drinking? Short-
term randomized trials of alcohol have shown changes in
insulin sensitivity and adiponectin concentrations within 6
to 8 weeks, suggesting that changes in subsequent risk of
diabetes could plausibly occur with a short latency (10–
12). Therefore, we attempted to examine whether initia-
tion of light to moderate alcohol consumption is
associated with a lower subsequent risk of type 2 diabetes,
and likewise whether a reduction in alcohol consumption
is associated with higher type 2 diabetes risk.
To accomplish these aims, we examined men enrolled in
the Health Professionals Follow-Up Study (HPFS), an
ongoing prospective cohort of men who have repeatedly
reported their alcohol consumption over time and in
whom validated diagnoses of diabetes have been ascer-
tained for two decades.
RESEARCH DESIGN AND METHODS
The HPFS is a prospective investigation of 51,529 U.S. male health profession-
als age 40–75 years at baseline in 1986 who returned a mailed questionnaire
about diet and medical history. Participants subsequently provided diet,
lifestyle, and medical information on biennial questionnaires. We excluded
men with missing data on BMI and physical activity at baseline. We also
excluded men who had implausible nutritional information (70 missing food
items or estimated daily energy intake 800 or 4,200 kcal). Furthermore, we
excluded men who had died or had been diagnosed with diabetes or cancer
(except for those with nonmelanoma skin cancer) before follow-up for these
analyses started (i.e., in 1990). After these exclusions, 38,031 participants
remained for the analyses.
To assess the association between changes in alcohol intake and biochem-
ical markers of glycemia, we examined a subset of men in this cohort who
participated in a nested case-control study of coronary heart disease. In 1994,
18,825 participants provided blood samples. Men who provided samples were
somewhat younger, but were otherwise similar to those who did not provide
samples. We matched 266 men with incident coronary heart disease until 2000
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date of blood draw, and smoking status on a 1:2 basis, as described previously
(13,14). All participants gave written informed consent, and the Harvard
School of Public Health Human Subjects Committee Review Board approved
the study protocol.
Assessment of alcohol consumption. In 1986, men reported their alcohol
consumption on a semiquantitative food frequency questionnaire (FFQ)
(15,16) that included
,separate items for beer, white wine, red wine, and liquor.
Participants were asked how often, on average over the previous year, they
had consumed each beverage. We calculated total alcohol intake by multiply-
ing the average consumption of each beverage by the published alcohol
content of the speciﬁed portion size based on periodically updated U.S.
Department of Agriculture food composition tables and then summing across
beverages (17). The FFQ was administered again every 4 years, with an item
for light beer added in 1994. We assessed the validity of self-reported alcohol
consumption by comparing estimated alcohol intake from the FFQ with the
intake derived from two 7-day dietary records among 127 participants who
returned questionnaires in 1986 and 1987 and resided in or near Boston,
Massachusetts. The Spearman rank correlation coefﬁcient between alcohol
intake estimated from the FFQ and corresponding intake from diet records
was 0.86 (18).
Assessment of lifestyle factors. Lifestyle factors were assessed biennially
using questionnaires that included questions about BMI, smoking, physical
activity, and medical conditions. Participants reported physical activity as the
average time engaged in speciﬁc activities during the previous year. Reported
weights have been shown to correlate well with measured weights (16), and
the assessment of physical activity was previously validated (19). We obtained
energy intake, coffee consumption, and energy-adjusted intakes of dietary
ﬁber, glycemic load, trans fat, and the ratio between polyunsaturated and
saturated fat from a semiquantitative FFQ (20). Glycemic load was calculated
by multiplying the amount of carbohydrates by the average glycemic index as
previously described (21).
Ascertainment of type 2 diabetes. Incident cases of type 2 diabetes were
identiﬁed by self report and conﬁrmed by a validated supplementary ques-
tionnaire detailing symptoms, diagnostic laboratory test results, and diabetes
treatment. The diagnosis was conﬁrmed if the participant reported at least one
of the following: treatment with insulin or oral hypoglycemic medication, at
least one classic symptom (excessive thirst, polyuria, weight loss, or hunger)
plus elevated plasma glucose level, or at least two elevated plasma glucose
concentrations on two different occasions in the absence of symptoms.
Elevated plasma glucose concentration was deﬁned as at least 140 mg/dl
(7.8 mmol/l), plasma glucose 200 mg/dl (11.1 mmol/l) nonfasting, or
plasma glucose 200 mg/dl (11.1 mmol/l) after 2 h during an oral glucose
tolerance test before 1998; for cases diagnosed in 1998 and later, the fasting
plasma glucose threshold was lowered to 126 mg/dl (7.0 mmol/l) (22). The
validity of self-reported diabetes has been conﬁrmed with medical record
reviews in a sample (23).
Measurement of biochemical variables. Blood samples were collected in
liquid EDTA tubes, placed on ice packs, stored in styrofoam containers,
returned to our laboratory via overnight courier, and centrifuged and ali-
quoted for storage in liquid nitrogen freezers (130°C or colder). Plasma total
adiponectin concentrations were measured by competitive radio-imunoassay
(Linco Research, St. Charles, Mo) for cases and controls ascertained through
2000 (n  798). Hemoglobin A1c (A1C) concentrations were measured by
turbidimetric immunoinhibition for cases and controls through 2004 (n 
1,365).
Statistical analysis. Each individual contributed person-time from the
return of the 1990 questionnaire to the date of diagnosis of type 2 diabetes,
date of diagnosis of cancer or death, or January 31, 2006, whichever came ﬁrst.
We used Cox proportional hazards models to calculate hazard ratios (HR) and
95% CI. We used change in alcohol consumption updated every 4 years as a
time-varying covariable, using an Anderson-Gill data structure (24). Thus, we
used the change in alcohol consumption between the 1986 and 1990 question-
naires to determine the risk for type 2 diabetes during the period from 1990 to
1994, the change in alcohol consumption based on the 1990 and 1994
questionnaires for the period from 1994 to 1998, and so on. In these analyses,
men contributed person-time only during each 4-year period in which they
provided data on alcohol consumption. We skipped contributions of person-
time for individuals with missing information on alcohol consumption during
follow-up for that speciﬁc period. In multivariate models, we adjusted for age
(ﬁve categories), BMI (eight categories: 23.0, 23.0–23.9, 24.0–24.9, 2.5–26.9,
2.7–28.9, 29.0–30.9, 31.0–34.9, or 35.0 kg/m
2), physical activity (quintiles),
smoking status (never, former, current 1–14 cigarettes/day, current 15–24
cigarettes/day or current 25 cigarettes/day), family history of type 2 diabetes
(yes or no), incident and prevalent cardiovascular disease (stroke, myocardial
infarction, coronary artery bypass surgery, or angina), hypertension, and
hypercholesterolemia, dietary glycemic load, ﬁber intake, trans fat intake,
ratio of polyunsaturated to saturated fat (all four in quintiles and energy-
adjusted), coffee intake (quintiles), and total energy intake (continuous). All
variables were treated as time-varying covariates in our models. Linear trends
across (change in) alcohol consumption categories were tested by treating the
median value of each category as a continuous variable.
Concentrations of total adiponectin and A1C per 7.5 g/day increment in
alcohol intake over 4 years (i.e., 1990–1994) were calculated with a mixed
analysis of variance model that included the same terms as the Cox regression
model and a term for case-control status with clustering on case-control
triads. The models were stratiﬁed by alcohol intake in 1990. For these
analyses, we excluded men with missing data on alcohol intake and with a
history of type 2 diabetes in 1994, leaving 697 and 1,188 men for the
adiponectin and A1C analyses, respectively.
RESULTS
In 1990, the ﬁrst update on alcohol consumption, most
subjects (55%) reported only modest changes in alcohol
consumption compared with 4 years earlier (Table 1). The
median change in alcohol consumption was 0 g/day. No
consistent trends were seen in potential confounders
among men who decreased or increased their alcohol
consumption.
Overall alcohol consumption and risk of type 2 dia-
betes. During 428,497 person-years of follow-up among
38,031 men, we documented 1,905 cases of newly diag-
nosed type 2 diabetes. We ﬁrst examined alcohol con-
sumption in grams per day and risk of diabetes. Compared
with abstention, HRs of type 2 diabetes after multivariable
adjustment were 1.04 (95% CI: 0.92–1.18) for alcohol
consumption of 0.1 to 4.9 g/day, 0.81 (95% CI: 0.69–0.94)
for 5 to 9.9 g/day, 0.70 (95% CI: 0.59–0.84) for 10 to 14.9
g/day, 0.71 (95% CI: 0.60–0.84) for 15 to 29.9 g/day, 0.54
(95% CI: 0.44–0.67) for 30 to 49.9 g/day, and 0.50 (95% CI:
0.36–0.69) for alcohol consumption of 50 or more grams
per day (Ptrend  0.0001).
Four-year changes in amount of alcohol intake and
risk of type 2 diabetes. The effect of a 7.5 g/day
(approximately half a glass) change in alcohol intake on
subsequent change in diabetes risk differed between initial
alcohol consumption levels (Pinteraction  0.01) (Table 2).
Such an increment had the largest association with risk on
men who were initially nondrinkers at the beginning of any
4-year period of change (HR 0.78; 95% CI: 0.60–1.00). This
was followed by men who initially consumed 1 glass/day
(HR 0.89; 95% CI: 0.83–0.96). A 4-year change in alcohol
intake was not associated with subsequent diabetes risk
among men who consumed 1 glass/day at the beginning
of the 4-year period (HR 0.99; 95% CI: 0.95–1.02).
In a sensitivity analysis, we repeated the analysis, ex-
cluding men with any missing alcohol data during follow-
up. This slightly strengthened the association of changes
in alcohol intake with risk among initial nondrinkers (HR
0.71; 95% CI: 0.52–0.98), but had little effect on initial 1
glass/day drinkers (HR 0.89; 95% CI: 0.82–0.96) and 1
glass/day drinkers (HR 0.99; 95% CI: 0.95–1.04). To mini-
mize potential bias related to total abstention from alcohol
due to poor health, we also excluded all current nondrink-
ers at the beginning of each follow-up period, with little
effect on the HRs (data not shown). Finally, we examined
whether changes in BMI and physical activity over time
could partially explain the observed relation. We assessed
this effect by including levels of BMI and physical activity
assessed at both the beginning and end of each 4-year
period used to calculate change in alcohol consumption,
while retaining all other variables in the model. This did
not materially inﬂuence our results (results not shown).
The association between changes in alcohol consumption
M.M. JOOSTEN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, JANUARY 2011 75and diabetes risk among the three strata of initial
drinkers did not substantially differ by subgroups of
BMI. The multivariable-adjusted relative risks for diabe-
tes associated with a 7.5 g/day increase in alcohol
among initial nondrinkers, 1 and 1 drink/day con-
sumers were 0.66 (95% CI: 0.42–1.04), 0.85 (95% CI:
0.76–0.94) and 0.98 (95% CI: 0.93–1.04) for men with a
BMI 28.3 kg/m
2 (median BMI of incident diabetes
cases) and 0.86 (95% CI: 0.65–1.14), 0.92 (95% CI:
0.84–1.02) and 0.99 (95% CI: 0.93–1.04) for men with a
BMI of 28.3 kg/m
2, respectively (Pinteraction  0.48).
Four-year changes in type of drinker and risk of type
2 diabetes. Compared with stable light drinkers (0–4.9
g/day), initial light drinkers who increased their intake to
moderate levels (5.0–29.9 g/day) had a signiﬁcantly lower
risk of type 2 diabetes (HR 0.75; 95% CI: 0.62–0.90) (Table
3). Conversely, moderate drinkers who reduced their
intake to none or light did not have a lower risk of diabetes
(HR 1.09; 95% CI: 0.92–1.30) after multivariable adjust-
ments compared with stable light drinkers. However,
stable moderate drinkers had signiﬁcantly lower risk of
diabetes compared with stable light drinkers (HR 0.74; 95%
CI: 0.65–0.83). Furthermore, all current moderate alcohol
consumption categories were associated with at least a
25% lower risk of type 2 diabetes compared with stable
light drinkers, regardless of initial alcohol consumption
category (Pinteraction  0.55). No further risk reductions
were observed among initial light or moderate drinkers
who increased their consumption 30.0 g/day. Similar
results were obtained when we reanalyzed the data ex-
TABLE 1
Characteristics according to 4-year change in alcohol consumption in 1990 stratiﬁed by initial intake in 1986 (n  33,073)*
Change in alcohol consumption 4 years later (g/day)
Initial alcohol consumption (g/day)
Moderate
to large
decrease
(7.5)
Small to
moderate
decrease
(2.5–7.49)
No change/
relatively
stable
(2.49)
Small to
moderate
increase
(2.5–7.49)
Moderate
to large
increase
(7.5)
Number drinks/day (0)
Number (% of total) of participants — — 6,868 (20.8%) 309 (0.9%) 170 (0.5%)
Age (years) — — 57.8 56.7 59.4
BMI (kg/m
2) — — 25.6 25.5 25.7
Weight gain from 1986 to 1990 (lb) — — 1.2 1.6 3.0
Alcohol consumption in 1986 (g/day) — — 0.0 0.0 0.0
Alcohol consumption in 1990 (g/day) — — 0.2 4.1 21.5
Physical activity (METs/week) — — 35.8 36.1 38.0
Current smoker (%) — — 3.4 3.7 5.0
Family history of diabetes (%)† — — 15.9 14.3 11.2
Cardiovascular disease (%)‡ — — 11.4 13.9 12.9
Hypertension (%) — — 25.6 26.3 25.3
Hypercholesterolemia (%) — — 28.4 35.9 29.2
1 drink/day (0.1–14.9)
Number (% of total) of participants 791 (2.4%) 3,517 (10.6%) 9,321 (28.2%) 2,391 (7.2%) 1,190 (3.6%)
Age (years) 58.9 57.3 57.1 56.7 57.6
BMI (kg/m
2) 25.5 25.5 25.5 25.4 25.7
Weight gain from 1986 to 1990 (lb) 0.2 1.0 1.3 1.6 1.7
Alcohol consumption in 1986 (g/day) 12.1 8.3 4.9 6.7 8.0
Alcohol consumption in 1990 (g/day) 2.3 3.9 4.7 11.2 24.5
Physical activity (METs/week) 37.8 38.6 36.1 40.3 38.4
Current smoker (%) 5.6 3.5 4.0 4.4 5.4
Family history of diabetes (%)† 14.9 15.6 16.1 15.3 14.5
Cardiovascular disease (%)‡ 10.9 11.6 11.3 10.9 10.1
Hypertension (%) 27.0 24.0 23.6 24.2 27.0
Hypercholesterolemia (%) 32.3 30.9 30.7 31.2 33.2
1 drink/day (15.0 g/day)
Number (% of total) of participants 3,256 (9.8) 1,498 (4.5) 2,118 (6.4) 665 (2.0) 979 (3.0)
Age (years) 58.7 57.7 58.8 57.7 58.4
BMI (kg/m
2) 25.7 25.4 25.4 25.2 25.6
Weight gain from 1986 to 1990 (lb) 1.1 1.5 1.6 1.5 1.9
Alcohol consumption in 1986 (g/day) 37.9 26.0 30.2 27.7 28.5
Alcohol consumption in 1990 (g/day) 16.4 21.2 30.1 32.2 49.2
Physical activity (METs/week) 39.5 40.2 38.1 39.8 39.7
Current smoker (%) 7.5 5.5 8.6 5.4 9.4
Family history of diabetes (%)† 13.4 15.4 13.7 12.2 13.5
Cardiovascular disease (%)‡ 11.4 10.9 10.3 9.5 8.8
Hypertension (%) 31.0 26.5 27.8 24.2 33.8
Hypercholesterolemia (%) 32.4 32.2 31.4 28.2 33.1
*Data are given as mean for continuous variables, except alcohol consumption (median) and percentage for categorical variables and are
age-adjusted, except for age. BMI was calculated as the weight in kilograms divided by height in meters squared. MET, metabolic equivalent.
Dash indicates data not available. †History of diabetes with onset at age 30 years in immediate family. ‡Cardiovascular disease comprises
stroke, myocardial infarction, coronary artery bypass surgery, and angina pectoris.
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missing alcohol data during follow-up (data not shown).
Four-year change in amount of alcohol intake and
effect on markers of glycemia. To test the robustness of
our ﬁndings, we next examined the 4-year change in
alcohol consumption from 1990–1994 on markers of gly-
cemia collected in 1994, stratiﬁed by initial alcohol con-
sumption in 1990 (Table 4). A similar interaction between
change in alcohol and baseline alcohol intake as in the
main analysis was observed for levels of total adiponectin
and A1C among nondiabetic men. For example, a 7.5 g/day
increment in alcohol intake, between 1990–1994, was
associated with a 1.2  0.3 g/ml (mean  SEM) higher
total adiponectin level in 1994 among men who were
nondrinkers at baseline, a 0.5  0.3 g/ml higher adiponec-
tin level among 1 glass/day drinkers, and a 0.6  0.3
g/ml lower level among 1 glass/day drinkers at baseline
(Pinteraction  0.002). For A1C, the inverse association
between change in alcohol intake in 1990–1994 and A1C
concentration was also strongest among nondrinkers com-
pared with 1 glass/day drinkers and 1 glass/day drink-
ers in 1990 (Pinteraction  0.02).
DISCUSSION
In this large prospective cohort study, we found that
4-year changes in alcohol consumption assessed repeat-
edly over time were followed by subsequent changes in
risk of type 2 diabetes. The lower risk associated with an
increase in alcohol consumption was dependent on initial
drinking levels, with no beneﬁt associated with increased
intake among men already drinking moderately. This pat-
tern of lower risk associated with increased alcohol con-
sumption solely among abstainers and light drinkers was
TABLE 2
Hazard ratios of type 2 diabetes according to updated 4-year changes in alcohol intake stratiﬁed by initial intake (n  38,031)
Change in alcohol consumption 4 years later (g/day)
Initial alcohol
consumption (g/day)
Moderate to
large decrease
(7.5)
Small to
moderate
decrease
(2.5–7.49)
No change/
relatively stable
( 2.49)
Small to
moderate
increase
(2.5–7.49)
Moderate to
large increase
(7.5)
Per 7.5 g/day
increase
Non (0)
Multivariable-adjusted* — — 1.00 Reference 0.84 (0.55–1.30) 0.63 (0.35–1.13) 0.78 (0.60–1.00)
Person-years — — 89,008 5,170 3,229
Number of cases — — 448 22 13
1 drink/day (0.1–14.9)
Multivariable-adjusted* 1.22 (0.90–1.66) 1.06 (0.89–1.26) 1.00 Reference 0.76 (0.63–0.91) 0.84 (0.68–1.03) 0.89 (0.83–0.96)
Person-years 7,446 33,804 113,714 42,162 26,600
Number of cases 45 165 534 145 112
1 drink/day (15.0)
Multivariable-adjusted* 1.18 (0.91–1.53) 1.14 (0.83–1.56) 1.00 Reference 1.04 (0.72–1.51) 0.90 (0.66–1.24) 0.99 (0.95–1.02)
Person-years 33,771 17,464 26,786 11,250 18,093
Number of cases 155 67 94 40 65
Pinteraction† 0.004
Dash indicates data not available. *Multivariable-adjusted hazard ratios (95% CIs) were calculated using Cox proportional hazards model and
adjusted for age (5 categories), BMI (8 categories), physical activity (quintiles), smoking status (never, former, current 1–14 cigarettes/day,
current 15–24 cigarettes/day, or current 25 cigarettes/day), family history of type 2 diabetes, incident and prevalent cardiovascular disease
(stroke, myocardial infarction, coronary artery bypass surgery, or angina), hypertension, and hypercholesterolemia, dietary glycemic load
(quintiles), ﬁber intake (quintiles), trans fat intake (quintiles), ratio of polyunsaturated fat and saturated fat (quintiles; all energy adjusted),
coffee intake (quintiles), and total energy intake (continuous). †Pinteraction value was derived by adding an interaction term between the 7.5
g/day increment in alcohol consumption (continuous) and initial alcohol consumption (categorical) in the multivariate model.
TABLE 3
Hazard ratios of type 2 diabetes according to updated 4-year changes in initial and current drinking category (n  38,031)
Initial alcohol drinking
category (g/day)
Alcohol drinking category 4 years later (g/day)
Light (0–4.9) Moderate (5.0–29.9) Heavier (30.0) Ptrend*
Light (0–4.9)
Multivariable-adjusted† 1.00 Reference 0.75 (0.62–0.90) 0.35 (0.11–1.10) 0.001
Person-years 169,623 31,723 1,127
Number of cases 875 125 3
Moderate (5.0–29.9)
Multivariable-adjusted† 1.09 (0.92–1.30) 0.74 (0.65–0.83) 0.59 (0.45–0.77) 0.001
Person-years 27,841 134,942 16,050
Number of cases 159 496 60
Heavier (30.0)
Multivariable-adjusted† 0.78 (0.44–1.38) 0.67 (0.52–0.88) 0.50 (0.40–0.63) 0.08
Person-years 2,089 15,036 30,067
Number of cases 12 65 110
*Ptrend values were derived from tests of linear trend across increasing categories of alcohol use by treating the median value of each category
as a continuous variable. †Hazard ratios (95% CIs) were calculated using Cox proportional hazards model and adjusted for the covariates
listed in Table 2.
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intake with total adiponectin and A1C.
Our results extend previous epidemiologic studies that
have reported an inverse association between moderate
alcohol consumption and the longer term risk of type 2
diabetes (1,2). Recent studies have shown that alcohol
consumption is associated with lower risk of type 2
diabetes even among low-risk individuals (lean, active
nonsmokers) (25,26) and when adjusted for multiple life-
style factors based on BMI, physical activity level, smoking
habits, and diet quality (27–29). Comparisons of different
beverage types generally suggest that ethanol rather than
the type of alcoholic beverage is responsible for this
association (23,30). Furthermore, variation in the ADH1C
gene, a gene that encodes the alcohol dehydrogenase 1C
enzyme that oxidizes ethanol, appears to modify the
association between alcohol consumption and type 2
diabetes risk, providing further epidemiologic support for
the causal nature of the relationship between alcohol
consumption and diabetes risk (31).
The plausibility of these observational results is sup-
ported by short-term randomized controlled trials on
changes in alcohol consumption (25–30 g/day) (10,11). In
these studies, moderate drinking signiﬁcantly improved
insulin sensitivity after 6 to 8 weeks. Also, clinical trials in
a variety of populations have shown that alcohol consump-
tion increases adiponectin (11,12,32,33), a hormone se-
creted by adipose tissue that appears to improve insulin
sensitivity. Indeed, adiponectin appears to explain 	25 to
30% of the inverse association between alcohol consump-
tion and type 2 diabetes in women (34) Finally, longer-
term randomized trials of 3 to 12 months among diabetic
individuals have shown that assignment to alcohol con-
sumption lowers fasting glucose (35) and A1C (36).
These ﬁndings from randomized trials suggest that the
effects of alcohol intake on glycemia may have a short
latency, as they appear within weeks of assignment to
alcohol. Our results are consistent with this ﬁnding, as the
more beneﬁcial metabolic parameters and the lower sub-
sequent risk of diabetes associated with an increase in
alcohol consumption were observed in the next follow-up
period. Our results further imply that the effect may be
transient, as a decrease in consumption was accompanied
by a modest increase in risk. Finally, our results highlight
that any beneﬁt of alcohol on glycemia and risk of diabetes
is restricted to moderate drinking, and increases among
those already drinking moderately confer no lower risk.
Several limitations warrant consideration. We relied on
self-reported alcohol consumption. However, validation
studies in these health professionals comparing self-ad-
ministered questionnaire with intake assessed by detailed
diet records showed correlations above 0.8 and mean and
SD values almost identical by the two methods (18).
Second, we do not know why men changed their intake.
However, we restricted our analysis to men with no
history of diabetes and cancer and adjusted for cardiovas-
cular disease, hypertension, and hypercholesterolemia.
Third, we do not know when during each 4-year interval
the change in alcohol consumption occurred, a limitation
that reﬂects the fact that the administered FFQ speciﬁcally
queries alcohol consumption in the previous year. There-
fore, we cannot deﬁnitely evaluate whether the change in
intake on type 2 diabetes risk is immediate. We do know,
however, that the change in alcohol preceded the diagno-
sis of diabetes. Fourth, we performed our analysis in male
health professionals, and results may therefore not be
readily generalizable to other populations. However,
within this homogenous group of highly educated men,
potential confounding because of social economic status
is substantially reduced. Fifth, we could not evaluate
changes in beverage types, given the more limited use of
any particular beverage compared with total alcohol use.
We previously found that all beverage types were inversely
associated with type 2 diabetes in this cohort (23). Finally,
as with any observational study, unaccounted factors
associated with changes in alcohol consumption and risk
of type 2 diabetes may introduce an unknown degree of
residual confounding, despite the substantial number of
potentially confounding factors we included.
In conclusion, in this cohort of male health profession-
als, increases in alcohol consumption over time were
associated with correspondingly lower 4-year risk of type
2 diabetes, although this association was limited to rare
and light drinkers at baseline. This suggests that the effect
of alcohol consumption on diabetes risk may have a
relatively short latency time but may also be transient and
reversible. Furthermore, individuals who already consume
alcohol in moderation may not further beneﬁt from in-
creased consumption. Although these results may suggest
that some individuals should consider adopting regular
and moderate intake of alcohol, our ﬁndings—even if
proven to be causal—are limited to a single outcome of
diabetes. Decisions and recommendations about changes
in alcohol consumption should, as with alcohol consump-
tion in general, consider the full range of risks and beneﬁts
to an individual, including the consistent harms to the
individual and society of drinking that exceeds recom-
mended limits.
TABLE 4
Associations of a 7.5 g/day increment in alcohol consumption
from 1990–1994 on subsequent total adiponectin and hemoglobin
A1c levels, classiﬁed by alcohol consumption in 1990
Alcohol consumption in
1990 (g/day)
Mean increment in glycemic
marker per 7.5 g/day increase in
alcohol consumption from
1990–1994
Total adiponectin
(g/ml) HbA1c (%)
Non (0)
Mean increment* 1.2  0.3 0.04  0.02
Number of participants 151 267
1 drink/day (0.1–14.9)
Mean increment* 0.5  0.3 0.02  0.02
Number of participants 355 610
1 drink/day (15.0)
Mean increment* 0.6  0.3 0.01  0.01
Number of participants 191 311
Pinteraction† 0.002 0.02
*Values are mean increments ( SEM) per 7.5 g/day increment in
alcohol consumption over 4 years and were calculated with a mixed
ANOVA model that included terms for age, BMI, physical activity,
smoking status, family history of type 2 diabetes, hypertension,
hypercholesterolemia, cardiovascular disease, dietary glycemic load,
ﬁber intake, trans fat intake, ratio of polyunsaturated fat and
saturated fat (all energy-adjusted), coffee intake, total energy intake,
and case-control status. †Pinteraction value was derived by adding an
interaction term between the 7.5 g/day increment of alcohol con-
sumption (continuous), and initial alcohol consumption in 1990
(categorical) in the mixed ANOVA model.
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